One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
Diabetes, Obesity and Metabolism
doi : 10.1111/dom.15137
Diabetes, Obesity and Metabolism: Volume 26, Issue 12
Glucagon-like peptide-1 receptor agonist-based agents and weight loss composition: Filling the gaps
doi : 10.1111/dom.15913
Non-invasive metabolic biomarkers in initial cognitive impairment in patients with diabetes: A systematic review and meta-analysis
doi : 10.1111/dom.15916
The use of composite endpoints in cardiovascular outcome trials for diabetes: A review of 22 randomized clinical trials published since 2008
doi : 10.1111/dom.15907
Cost-effectiveness of sodium-glucose cotransporter-2 inhibitors in the treatment of diabetic nephropathy in Japan
doi : 10.1111/dom.15832
Serum levels of the incretin-like peptide 26RFa are diminished in women living with obesity and diabetes and restored after sleeve gastrectomy: Results from the prospective pilot RFa-Ba-S study
doi : 10.1111/dom.15871
Psychosocial outcomes with the Omnipod® 5 Automated Insulin Delivery System in caregivers of very young children with type 1 diabetes
doi : 10.1111/dom.15906
An internet-based platform with a low-calorie dietary intervention improves cardiometabolic risk factors in overweight and obese people in China: Half-year follow-up results of a randomized controlled trial
doi : 10.1111/dom.15919
Causal relationship between key genes and metabolic dysfunction-associated fatty liver disease risk mediated by immune cells: A Mendelian randomization and mediation analysis
doi : 10.1111/dom.15925
Evaluating remission of type 2 diabetes using a metabolic intervention including fixed-ratio insulin degludec and liraglutide: A randomized controlled trial
doi : 10.1111/dom.15926
Association of N-terminal pro-B natriuretic peptide with all-cause mortality and cardiovascular mortality in obese and non-obese populations and the development of a machine learning prediction model: National Health and Nutrition Examination Survey (NHANES) 1999–2004
doi : 10.1111/dom.15927
Relationship between weight-adjusted-waist index and all-cause and cardiovascular mortality in individuals with type 2 diabetes
doi : 10.1111/dom.15929
Trends in pharmacological management of paediatric patients with type 2 diabetes from 2000 to 2023 in German-speaking countries: Analysis based on the Diabetes Prospective Follow-up Registry
doi : 10.1111/dom.15930
Prevalence of obesity and cardiovascular disease in adults with type 2 diabetes and use of diabetes medication in Germany: A claims data study
doi : 10.1111/dom.15931
Integrated approach of machine learning, Mendelian randomization and experimental validation for biomarker discovery in diabetic nephropathy
doi : 10.1111/dom.15933
Real-world evaluation of the effects of tirzepatide in patients with type 2 diabetes mellitus
doi : 10.1111/dom.15934
Lipids and apolipoproteins and the risk of vascular disease and mortality outcomes in women and men with type 2 diabetes in the ADVANCE study
doi : 10.1111/dom.15935
The association of glycaemic risk factors and diabetes duration with risk of heart failure in people with type 2 diabetes: A systematic review and meta-analysis
doi : 10.1111/dom.15938
A novel, centrally acting mammalian aminosterol, ENT-03, induces weight loss in obese and lean rodents
doi : 10.1111/dom.15940
Efficacy of vitamin D supplementation on glycaemic control in type 2 diabetes: An updated systematic review and meta-analysis of randomized controlled trials
doi : 10.1111/dom.15941
Sodium-glucose cotransporter 2 inhibitors and the risk of Parkinson disease in real-world patients with type 2 diabetes
doi : 10.1111/dom.15943
Detection of hypoglycaemia in type 1 diabetes through breath volatile organic compound profiling using gas chromatography–ion mobility spectrometry
doi : 10.1111/dom.15944
Diosgenin ameliorating non-alcoholic fatty liver disease via Nrf2-mediated regulation of oxidative stress and ferroptosis
doi : 10.1111/dom.15945
Associations between cuprotosis-related genes and the spectrum of metabolic dysfunction-associated fatty liver disease: An exploratory study
doi : 10.1111/dom.15946
Synergies between diabetes and hyperhomocysteinaemia: New insights to predict and prevent adverse cardiovascular effects
doi : 10.1111/dom.15947
In which common chronic conditions can (or cannot) obesity and lifestyle factors explain higher concentrations of C-reactive protein?
doi : 10.1111/dom.15949
Diabetes mellitus and adverse clinical events in patients with atrial fibrillation: A report from the GLORIA-AF registry phase III
doi : 10.1111/dom.15950
Cagrilintide is not associated with clinically relevant QTc prolongation: A thorough QT study in healthy participants
doi : 10.1111/dom.15951
Glycaemic and weight effects of metabolic surgery or semaglutide in diabetes dosage for patients with type 2 diabetes
doi : 10.1111/dom.15952
Visceral and subcutaneous adiposity and cardiovascular disease: Unravelling associations and prognostic value
doi : 10.1111/dom.15953
Association between estimated glucose disposal rate and cardiovascular mortality across the spectrum of glucose tolerance in the US population
doi : 10.1111/dom.15954
The interdependence of targets for continuous glucose monitoring outcomes in type 1 diabetes with automated insulin delivery
doi : 10.1111/dom.15955
Coronary artery disease risk prediction by combined stratification of low-density lipoprotein-cholesterol and high-density lipoprotein-cholesterol levels across different glucose statuses
doi : 10.1111/dom.15956
The impact of vildagliptin as an add-on therapy on matrix metalloproteinase-14 levels, liver stiffness and subclinical atherosclerosis in adolescents with type 1 diabetes and non-alcoholic steatohepatitis: A randomized controlled trial
doi : 10.1111/dom.15958
Association of metabolic score for visceral fat with all-cause mortality, cardiovascular mortality, and cancer mortality: A prospective cohort study
doi : 10.1111/dom.15959
Efficacy and safety of once-weekly insulin icodec versus once-daily basal insulin in Japanese individuals with type 2 diabetes: A subgroup analysis of the ONWARDS 1, 2 and 4 trials
doi : 10.1111/dom.15960
Glycaemic control metrics and metabolic dysfunction–associated steatotic liver disease in children and adolescents with type 1 diabetes
doi : 10.1111/dom.15961
Metformin continuation post-metabolic bariatric surgery and relapse of diabetes
doi : 10.1111/dom.15962
Are patients with newly diagnosed frozen shoulder more likely to be diagnosed with type 2 diabetes? A cohort study in UK electronic health records
doi : 10.1111/dom.15965
Association of a composite trait for anthropometrics, adiposity and energy expenditure with cardiometabolic diseases: An age-stratified cohort and genetic risk score analysis
doi : 10.1111/dom.15966
Semaglutide in patients with kidney failure and obesity undergoing dialysis and wishing to be transplanted: A prospective, observational, open-label study
doi : 10.1111/dom.15967
iGlarLixi effectively reduces residual hyperglycaemia in Chinese people with type 2 diabetes on basal insulin: A post hoc analysis of the LixiLan-L-CN study
doi : 10.1111/dom.15968
Cross-country inequalities in disease burden and care quality of chronic kidney disease due to type 2 diabetes mellitus, 1990–2021: Findings from the global burden of disease study 2021
doi : 10.1111/dom.15969
Global and regional estimates of hip fracture burden associated with type 1 diabetes from 1990 to 2021
doi : 10.1111/dom.15970
The liver fibrosis-8 index is a predictor for all-cause mortality in cardiovascular disease patients: A cohort study
doi : 10.1111/dom.15971
Tirzepatide, a dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide 1 receptor agonist, exhibits favourable effects on pancreatic β-cells and hepatic steatosis in obese type 2 diabetic db/db mice
doi : 10.1111/dom.15972
Cost–utility analysis and drug pricing of once-weekly insulin icodec versus once-daily insulin degludec for type 2 diabetes patients treated with basal insulin in China
doi : 10.1111/dom.15973
Remission and relapse of diabetes after sleeve gastrectomy and one-anastomosis gastric bypass: The Tehran Obesity Treatment Study
doi : 10.1111/dom.15974
Mendelian randomization analysis of the association between childhood overweight or obesity and gestational diabetes mellitus
doi : 10.1111/dom.15975
Associations of metabolic syndrome with cognitive function and dementia risk: Evidence from the UK Biobank cohort
doi : 10.1111/dom.15977
The coexistence of low muscle mass and obesity evaluated by dual energy X-ray absorptiometry, rather than low muscle mass or obesity alone, is associated with macrovascular but not microvascular complications in patients with type 2 diabetes mellitus
doi : 10.1111/dom.15978
Effects of glucagon-like peptide-1 receptor agonists on glycated haemoglobin and continuous glucose monitoring metrics as adjunctive therapy to insulin in adults with type 1 diabetes: A meta-analysis of randomized controlled trials
doi : 10.1111/dom.15979
Long-term outcomes of metabolic surgery versus medical/lifestyle therapy on metabolic dysfunction-associated fatty liver disease in adults with obesity and type 2 diabetes
doi : 10.1111/dom.15932
Tirzepatide, a dual receptor agonist of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1, enhances β-cell survival and maintenance markers in obese diabetic ovariectomized mice
doi : 10.1111/dom.15937
Absence of a glucose-lowering effect in glucose clamp procedures with a long-acting insulin analogue
doi : 10.1111/dom.15939
Representation of women in randomized controlled trials of novel antidiabetic drugs: A cohort study
doi : 10.1111/dom.15942
Hepatobiliary effects and safety of tirzepatide: A systematic review and meta-analysis
doi : 10.1111/dom.15948
Do nonglycaemic effects such as weight loss account for HbA1c lowering with efpeglenatide?: Insights from the AMPLITUDE-O trial
doi : 10.1111/dom.15957
Does the Cox proportional hazards model accurately reflect the dynamics of kidney outcomes? An exploration of superior alternatives
doi : 10.1111/dom.15928
Ethnic variation in the relationship between ectopic fat and insulin resistance: Potential contributions of deep subcutaneous adipose tissue, rs1443512 in HOTAIR, and rs6712203 in COBLL1
doi : 10.1111/dom.15980
